Screener
Total Revenue
Breakdown
Segments
AVAIView metric
CardiologyView metric
Central Nervous SystemView metric
MetabolicView metric
OtherView metric
OncologyView metric
| Segment | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Other | $124.73M | $122.87M | $148.02M | $147.87M | $199.26M | $249.81M | $237.56M | $219.07M |
| Metabolic | $164.92M | $168.17M | $170.48M | $188.56M | $192.64M | $195.92M | $201.24M | $209.37M |
| Oncology | $107.37M | $103.18M | $95.84M | $118.06M | $106.4M | $88.25M | $93.32M | $98.28M |
| Cardiology | $42.1M | $49.22M | $54.9M | $61.13M | $65.63M | $73.18M | $80.21M | $82.86M |
| Central Nervous System | $55.81M | $58.3M | $58.28M | $58.58M | $59.47M | $63.04M | $56.26M | $59.98M |
| AVAI | $38.38M | $34.84M | $31.06M | $29.11M | $36.52M | $38.25M | $38.02M | $37.77M |
| Total | $533.32M | $536.59M | $558.57M | $603.31M | $659.9M | $708.45M | $706.6M | $707.33M |